Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to -$8.8 million.

  • Ascendis Pharma A's Change in Account Payables fell 749.21% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 12152.95%. This contributed to the annual value of $29.2 million for FY2024, which is 20124.8% up from last year.
  • According to the latest figures from Q3 2025, Ascendis Pharma A's Change in Account Payables is -$8.8 million, which was down 749.21% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Change in Account Payables registered a high of $51.2 million during Q3 2021, and its lowest value of -$43.5 million during Q4 2023.
  • For the 5-year period, Ascendis Pharma A's Change in Account Payables averaged around $3.1 million, with its median value being $4.7 million (2023).
  • Data for Ascendis Pharma A's Change in Account Payables shows a peak YoY increase of 41384.34% (in 2023) and a maximum YoY decrease of 28193.49% (in 2023) over the last 5 years.
  • Ascendis Pharma A's Change in Account Payables (Quarter) stood at -$17.3 million in 2021, then skyrocketed by 238.15% to $23.9 million in 2022, then crashed by 281.93% to -$43.5 million in 2023, then soared by 210.62% to $48.1 million in 2024, then tumbled by 118.31% to -$8.8 million in 2025.
  • Its Change in Account Payables stands at -$8.8 million for Q3 2025, versus $17.2 million for Q2 2025 and -$42.9 million for Q1 2025.